The US Senate has moved to spare the world’s biggest HIV treatment and prevention programme – which funds drugs and research in more than 50 countries – from $400m (£298m) of aid cuts imposed by ...

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...

The World Health Organization has released new guidelines which, for the first time, recommend the use of an injectable form ...

HEALTH and Child Care minister Douglas Mombeshora has reaffirmed the country’s commitment to advancing HIV research, ...

A monthly pill would add to the growing number of choices for HIV preexposure prophylaxis, which is now seen as the best hope ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

The U.S. Senate has opened debate on a $9 billion rescission bill to claw back foreign aid and other funding not aligned with ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

An investigational once-weekly oral antiretroviral therapy (ART) combination effectively maintained viral suppression in ...

HIV pharma leaders are in Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...